SI2370446T1 - Derivati 6-cikloamino-3-(1H-pirolo(2,3-B)piridin-4-il)imidazo(1,2-B) piridazina, njihova priprava in terapevtska uporaba - Google Patents
Derivati 6-cikloamino-3-(1H-pirolo(2,3-B)piridin-4-il)imidazo(1,2-B) piridazina, njihova priprava in terapevtska uporabaInfo
- Publication number
- SI2370446T1 SI2370446T1 SI200931370T SI200931370T SI2370446T1 SI 2370446 T1 SI2370446 T1 SI 2370446T1 SI 200931370 T SI200931370 T SI 200931370T SI 200931370 T SI200931370 T SI 200931370T SI 2370446 T1 SI2370446 T1 SI 2370446T1
- Authority
- SI
- Slovenia
- Prior art keywords
- cycloamino
- pyrrolo
- imidazo
- pyridin
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0806723A FR2939134A1 (fr) | 2008-12-01 | 2008-12-01 | Derives de 6-cycloamino-3-(1h-pyrrolo°2,3-b!pyridin-4-yl) imidazo°1,2-b!-pyridazine, leur preparation et leur application en therapeutique |
EP09797121.2A EP2370446B1 (fr) | 2008-12-01 | 2009-11-30 | DÉRIVÉS DE 6-CYCLOAMINO-3-(1H-PYRROLO[2,3-b]PYRIDIN-4-YL)IMIDAZO[1,2-b]-PYRIDAZINE, LEUR PRÉPARATION ET LEUR APPLICATION EN THÉRAPEUTIQUE |
PCT/FR2009/052336 WO2010063929A1 (fr) | 2008-12-01 | 2009-11-30 | DERIVES DE 6-CYCLOAMINO-3-(1H-PYRROLO[2,3-b]PYRIDIN-4-YL)IMIDAZO[1,2-b]-PYRIDAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2370446T1 true SI2370446T1 (sl) | 2016-03-31 |
Family
ID=40383902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200931370T SI2370446T1 (sl) | 2008-12-01 | 2009-11-30 | Derivati 6-cikloamino-3-(1H-pirolo(2,3-B)piridin-4-il)imidazo(1,2-B) piridazina, njihova priprava in terapevtska uporaba |
Country Status (27)
Country | Link |
---|---|
US (1) | US8546395B2 (sl) |
EP (1) | EP2370446B1 (sl) |
JP (1) | JP5677309B2 (sl) |
KR (1) | KR20110082094A (sl) |
CN (1) | CN102232079A (sl) |
AR (1) | AR074237A1 (sl) |
AU (1) | AU2009323968A1 (sl) |
BR (1) | BRPI0922760A2 (sl) |
CA (1) | CA2743560A1 (sl) |
CY (1) | CY1117529T1 (sl) |
DK (1) | DK2370446T3 (sl) |
ES (1) | ES2563085T3 (sl) |
FR (1) | FR2939134A1 (sl) |
HR (1) | HRP20160173T1 (sl) |
HU (1) | HUE028525T2 (sl) |
IL (1) | IL213208A0 (sl) |
MX (1) | MX2011005808A (sl) |
PA (1) | PA8849801A1 (sl) |
PL (1) | PL2370446T3 (sl) |
PT (1) | PT2370446E (sl) |
RS (1) | RS54656B1 (sl) |
RU (1) | RU2011126981A (sl) |
SG (1) | SG172757A1 (sl) |
SI (1) | SI2370446T1 (sl) |
TW (1) | TW201033209A (sl) |
UY (1) | UY32280A (sl) |
WO (1) | WO2010063929A1 (sl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2137162T3 (en) * | 2007-03-15 | 2018-11-26 | Novartis Ag | Organic compounds and their applications |
US20100041663A1 (en) | 2008-07-18 | 2010-02-18 | Novartis Ag | Organic Compounds as Smo Inhibitors |
US9284319B2 (en) * | 2011-06-22 | 2016-03-15 | Bayer Intellectual Property Gmbh | Heterocyclyl aminoimidazopyridazines |
CN115298183A (zh) * | 2020-03-27 | 2022-11-04 | 北京原基华毅生物科技有限公司 | 作为酪蛋白激酶抑制剂的化合物 |
US11939328B2 (en) | 2021-10-14 | 2024-03-26 | Incyte Corporation | Quinoline compounds as inhibitors of KRAS |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0417520A (pt) | 2003-12-11 | 2007-03-06 | Aventis Pharma Inc | 1h-pirrolo[3,2-b, 3,2-c, e 2,3-c]piridina-2-carboxamidas substituìdas e análogos relatados como inibidores de caseìna cinase i-epsilon |
DE102005042742A1 (de) * | 2005-09-02 | 2007-03-08 | Schering Ag | Substituierte Imidazo[1,2b]pyridazine als Kinase-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel |
US7750000B2 (en) * | 2005-09-02 | 2010-07-06 | Bayer Schering Pharma Ag | Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments |
AR064420A1 (es) * | 2006-12-21 | 2009-04-01 | Alcon Mfg Ltd | Composiciones farmaceuticas oftalmicas que comprenden una cantidad efectiva de analogos de 6-aminoimidazo[1,2b]piridazinas, utiles para el tratamiento del glaucoma y/o controlar la presion intraocular normal o elevada(iop). |
MX2009012066A (es) * | 2007-05-09 | 2009-11-19 | Novartis Ag | Imidazopirinas sustituidas como inhibidoras de cinasa de lipido p13k. |
WO2008141065A1 (en) * | 2007-05-10 | 2008-11-20 | Smithkline Beecham Corporation | Quinoxaline derivatives as p13 kinase inhibitors |
AR067326A1 (es) * | 2007-05-11 | 2009-10-07 | Novartis Ag | Imidazopiridinas y pirrolo -pirimidinas sustituidas como inhibidores de cinasa de lipido |
FR2918061B1 (fr) * | 2007-06-28 | 2010-10-22 | Sanofi Aventis | Derives de 6-cycloamino-3-(pyridin-4-yl)imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique. |
FR2918986B1 (fr) * | 2007-07-19 | 2009-09-04 | Sanofi Aventis Sa | Derives de 6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]- pyridazine, leur preparation et leur application en therapeutique |
-
2008
- 2008-12-01 FR FR0806723A patent/FR2939134A1/fr active Pending
-
2009
- 2009-11-25 PA PA20098849801A patent/PA8849801A1/es unknown
- 2009-11-30 AR ARP090104598A patent/AR074237A1/es unknown
- 2009-11-30 ES ES09797121.2T patent/ES2563085T3/es active Active
- 2009-11-30 WO PCT/FR2009/052336 patent/WO2010063929A1/fr active Application Filing
- 2009-11-30 RS RS20160093A patent/RS54656B1/en unknown
- 2009-11-30 SG SG2011038361A patent/SG172757A1/en unknown
- 2009-11-30 SI SI200931370T patent/SI2370446T1/sl unknown
- 2009-11-30 CN CN2009801481699A patent/CN102232079A/zh active Pending
- 2009-11-30 PL PL09797121T patent/PL2370446T3/pl unknown
- 2009-11-30 RU RU2011126981/04A patent/RU2011126981A/ru unknown
- 2009-11-30 EP EP09797121.2A patent/EP2370446B1/fr active Active
- 2009-11-30 CA CA2743560A patent/CA2743560A1/fr not_active Abandoned
- 2009-11-30 JP JP2011538042A patent/JP5677309B2/ja not_active Expired - Fee Related
- 2009-11-30 BR BRPI0922760-1A patent/BRPI0922760A2/pt not_active IP Right Cessation
- 2009-11-30 MX MX2011005808A patent/MX2011005808A/es not_active Application Discontinuation
- 2009-11-30 DK DK09797121.2T patent/DK2370446T3/en active
- 2009-11-30 TW TW098140839A patent/TW201033209A/zh unknown
- 2009-11-30 PT PT97971212T patent/PT2370446E/pt unknown
- 2009-11-30 US US13/128,998 patent/US8546395B2/en not_active Expired - Fee Related
- 2009-11-30 AU AU2009323968A patent/AU2009323968A1/en not_active Abandoned
- 2009-11-30 HU HUE09797121A patent/HUE028525T2/hu unknown
- 2009-11-30 KR KR1020117015085A patent/KR20110082094A/ko not_active Application Discontinuation
- 2009-12-01 UY UY0001032280A patent/UY32280A/es not_active Application Discontinuation
-
2011
- 2011-05-29 IL IL213208A patent/IL213208A0/en unknown
-
2016
- 2016-02-16 HR HRP20160173T patent/HRP20160173T1/hr unknown
- 2016-02-24 CY CY20161100152T patent/CY1117529T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2563085T3 (es) | 2016-03-10 |
SG172757A1 (en) | 2011-08-29 |
HUE028525T2 (hu) | 2016-12-28 |
JP2012510453A (ja) | 2012-05-10 |
AU2009323968A1 (en) | 2010-06-10 |
KR20110082094A (ko) | 2011-07-15 |
JP5677309B2 (ja) | 2015-02-25 |
RU2011126981A (ru) | 2013-01-10 |
TW201033209A (en) | 2010-09-16 |
PA8849801A1 (es) | 2010-07-27 |
CN102232079A (zh) | 2011-11-02 |
DK2370446T3 (en) | 2016-02-22 |
CY1117529T1 (el) | 2017-04-26 |
AR074237A1 (es) | 2010-12-29 |
UY32280A (es) | 2010-06-30 |
PL2370446T3 (pl) | 2016-05-31 |
PT2370446E (pt) | 2016-03-22 |
US20120010208A1 (en) | 2012-01-12 |
IL213208A0 (en) | 2011-07-31 |
FR2939134A1 (fr) | 2010-06-04 |
BRPI0922760A2 (pt) | 2018-11-06 |
EP2370446A1 (fr) | 2011-10-05 |
EP2370446B1 (fr) | 2015-11-25 |
RS54656B1 (en) | 2016-08-31 |
WO2010063929A1 (fr) | 2010-06-10 |
US8546395B2 (en) | 2013-10-01 |
HRP20160173T1 (hr) | 2016-03-25 |
CA2743560A1 (fr) | 2010-06-10 |
MX2011005808A (es) | 2011-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200909186B (en) | 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives,preparation thereof and therapeutic use thereof | |
HK1253364A1 (zh) | 1h-吡唑並[3,4-b]吡啶及其治療應用 | |
IL201471A0 (en) | Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof | |
IL211141A0 (en) | 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof, and therapeutic application thereof | |
IL219424A0 (en) | IMIDAZO [1,2-b] PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS | |
IL225232A0 (en) | History of imidazo[1,2–b]pyridazine and imidazo[4,5,b]pyridine as jak inhibitors | |
ZA201004524B (en) | Pyrido[2,3-b]pyrazine-8-substituted compounds and their use | |
ZA200907679B (en) | 9- (pyrazol- 3 -yl) -9h-purine-2 -amine and 3- (pyrazol-3-yl) -3h-imidazo [4, 5-B) pyridin-5-amine derivatives and their use for the treatment of cancer | |
EP2387315A4 (en) | IMIDAZO [1,2-A] PYRIDINES AND IMIDAZO [1,2-B] PYRIDAZINES AS MARK KINASE INHIBITORS | |
IL211693A (en) | Annotations3 –– Cyano – 6– (Amino Converted) –8– (Optionally Converted Amino) –Imidazo [2,1– b] Pyridazine and Pharmaceuticals Containing Them | |
IL201450A0 (en) | Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof | |
ZA201006728B (en) | Polysubstituted 2-aryl-6-phenyl-imidazo[1,2-a]pyridine derivatives,and preparation and therapeutic use thereof | |
IL206673A0 (en) | Imidazo[1,2-a]pyridine-2-carboxamide derivatives, their preparation and their therapeutic application | |
IL215286A0 (en) | 9h-pyrrolo[2,3-b:5,4-c]dipridine azacarboline derivatives, preparation thereof, and therapeutic use thereof | |
IL217294A0 (en) | Novel 2,3 - dihydro -1h -imidazo (1,2-a)pyrimidin -5-one derivatives, preparation thereof, and pharamceutical use thereof | |
PL2448940T3 (pl) | Pochodne 6,7,8,9-tetrahydro-pirymido{1,2-a} pirymidyn-4-onu, ich wytwarzanie i zastosowanie farmaceutyczne | |
ZA201307511B (en) | Pyrido [2,3-b] pyrazine derivatives and their therapeutical uses | |
IL213208A0 (en) | 6-cycloamino-3-(1h-pyrrolo[2,3-b]pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof | |
IL206671A0 (en) | N-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | |
IL197500A0 (en) | Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof | |
IL213581A0 (en) | Derivatives of 6-cycloamino-2-thienyl-3-(pyridin-4-yl)imidazo [1,2-b]-pyridazine and 6-cycloamino-2-furanyl-3-(pyridin-4-yl)imidazo [1,2-b]-pyridazine, preparation and therapeutic application thereof | |
IL220448A (en) | Pyridine [3,2 - d] Pyrimidine - 7 (8h) - Their medical uses and uses | |
IL206669A0 (en) | 6-HETEROCYCLIC IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | |
ZA201004520B (en) | N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds,preparation thereof and therapeutic application thereof | |
IL206672A0 (en) | N-HETEROCYCLIC-6-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF |